L
Lamictal®
(lamotrigine)
Lamisil Oral Granules®
(terbinafine hydrochloride)
Lanoxin®
(digoxin)
Lantus®
(insulin glargine)
Lasix® Tablets
(furosemide)
Lescol®/Lescol® XL
(fluvastatin sodium)
Leukeran®
(chlorambucil)
Levaquin®*
(levofloxacin)
Levoxyl
(levothyroxine sodium)
Lexiva®
(fosamprenavir calcium)
Lincocin®
(lincomycin hydrochloride)
Lipitor®
(atorvastatin calcium)
Lipitor® 10 mg Tablets Unit-Dose Pak
(atorvastatin calcium)
Lipitor® 20 mg Tablets Unit-Dose Pak
(atorvastatin calcium)
Lipitor® 40 mg Tablets Unit-Dose Pak
(atorvastatin calcium)
Lipitor® 80 mg Tablets Unit-Dose Pak
(atorvastatin calcium)
Lomotil® 2.5 mg/.025 mg Tablets C-V
(diphenoxylate hydrochloride/atropine sulfate)
Lomotil® 2.5 mg/.025 mg 5 mL Liquid C-V
(diphenoxylate hydrochloride/atropine sulfate)
Loniten®
(minoxidil)
Lopid®
(gemfibrozil)
Lovaza™
(omega-3-acid ethyl esters)
Lovenox®
(enoxaparin sodium injection)
Lyrica®
(pregabalin)
Lyrica® 50 mg Capsules Unit-Dose Pak C-V
(pregabalin)
Lyrica® 75 mg Capsules Unit-Dose Pak C-V
(pregabalin)
Lyrica® 100 mg Capsules Unit-Dose Pak C-V
(pregabalin)
Lyrica® 150 mg Capsules Unit-Dose Pak C-V
(pregabalin)
| Together Rx Access is a trademark of Together Rx Access, LLC. All other marks are the property of their respective owners.
* Abilify Tablets are manufactured by Otsuka Pharmaceutical Co, Ltd, Tokyo, 101-8535 Japan or Bristol-Myers Squibb Company, Princeton, NJ 08543 USA. Distributed and marketed by Otsuka America Pharmaceutical, Inc, Rockville, MD 20850 USA. Marketed by Bristol-Myers Squibb Company, Princeton, NJ 08543 USA. Avapro and Plavix are distributed by Bristol-Myers Squibb Sanofi-Synthelabo Partnership, New York, NY 10016. LEVAQUIN® is a registered trademark of Daiichi Pharmaceutical, Co. VESIcare® is marketed by Yamanouchi Pharma America, Inc. (to be known as Astellas Pharma US, Inc., as of 4/1/05) and GlaxoSmithKline.
Certain limitations may apply with respect to specific drugs.
|
|